Results 161 to 170 of about 15,651 (253)

Cardiovascular Outcomes With SGLT‐2 Inhibitors in Patients With Type 2 Diabetes and Obstructive Sleep Apnoea: A Real‐World Analysis

open access: yes
Diabetes, Obesity and Metabolism, EarlyView.
Reuben L. Odai   +7 more
wiley   +1 more source

Impact of a Case‐Based Sleep Apnoea Education on the Knowledge, Attitudes and Confidence of Dental Hygiene Students—A Multicentre Intervention Study

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Objective This pilot study aimed to explore knowledge, attitudes and confidence levels of Obstructive Sleep Apnoea (OSA) before and after case‐based education among dental hygiene students. Moreover, to give an international perspective, this study included students from the US and Scandinavia. Methods A longitudinal multicentre study assessed
Ann‐Catrin André Kramer   +6 more
wiley   +1 more source

Prevalence of Dental Caries in Persons With or Without Long‐Term Experience of Positive Airway Pressure‐Treated Obstructive Sleep Apnoea

open access: yesInternational Journal of Dental Hygiene, EarlyView.
ABSTRACT Oral dryness is common in persons with untreated obstructive sleep apnoea (OSA) as well as in those using positive airway pressure (PAP). OSA with or without PAP treatment could therefore be a risk factor of dental caries. Objectives To describe and compare the prevalence of dental caries among persons with or without PAP‐treated OSA.
H. Ahonen   +6 more
wiley   +1 more source

Continuous positive airway pressure usage before and after issue of an urgent product defect correction notice following a global Philips recall

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Following the global recall of three to four million Philips continuous positive airway pressure (CPAP) devices in 2021 due to emissions of harmful products, the Therapeutic Goods Administration (TGA) issued guidance recommending continuing usage, stating discontinuing treatment could be immediately harmful.
Kirra Liu   +3 more
wiley   +1 more source

Healthcare costs of managing MAFLD are mostly driven by hospitalisation and advanced fibrosis: cost‐analysis from a tertiary‐care, multi‐disciplinary MAFLD clinic

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background and Aims Patients with metabolic (dysfunction)‐associated fatty liver disease (MAFLD) are frequently multimorbid, putting upward pressure on healthcare costs compared to other liver diseases. As Australian data are limited on expenditures in managing MAFLD, we evaluated hospital‐related costs and predictors of costs in patients ...
Natalie Ngu   +7 more
wiley   +1 more source

Idiopathic Pulmonary Fibrosis update, comparing the Australasian Interstitial Lung Disease Registry to the Australian Idiopathic Pulmonary Fibrosis Registry

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background and aims Real‐world evaluation of clinical characteristics and treatment profile of patients with idiopathic pulmonary fibrosis (IPF) is needed to establish areas for improvement according to evidence‐based recommendations. This study evaluated the clinical characteristics and treatment profile of patients with IPF from the ...
Michelle Chee   +31 more
wiley   +1 more source

Home - About - Disclaimer - Privacy